Clinician's use of the Statin Choice decision aid in patients with diabetes: a videographic study nested in a randomized trial

J Eval Clin Pract. 2009 Jun;15(3):492-7. doi: 10.1111/j.1365-2753.2008.01048.x. Epub 2009 Apr 2.

Abstract

Objective: To describe how clinicians use decision aids.

Background: A 98-patient factorial-design randomized trial of the Statin Choice decision vs. standard educational pamphlet; each participant had a 1:4 chance of receiving the decision aid during the encounter with the clinician resulting in 22 eligible encounters.

Design: Two researchers working independently and in duplicate reviewed and coded the 22 encounter videos.

Setting and participants: Twenty-two patients with diabetes (57% of them on statins) and six endocrinologists working in a referral diabetes clinic randomly assigned to use the decision aid during the consultation.

Main outcome measures: Proportion and nature of unintended use of the Statin Choice decision aid.

Results: We found eight encounters involving six clinicians who did not use the decision aid as intended either by not using it at all (n = 5; one clinician did use the decision aid in three encounters), offering inaccurate quantitative and probabilistic information about the risks and benefits of statins (n = 2), or using the decision aid to advance the agenda that all patients with diabetes should take statin (n = 1). Clinicians used the decision aid as intended in all other encounters.

Conclusions: Unintended decision aid use in the context of videotaped encounters in a practical randomized trial was common. These instances offer insights to researchers seeking to design and implement effective decision aids for use during the clinical visit, particularly when clinicians may prefer to proceed in ways that the decision aid apparently contradicts.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Choice Behavior*
  • Decision Support Systems, Clinical*
  • Diabetes Mellitus
  • Health Personnel*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Video Recording

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors